Johns Hopkins HIV GuideBrand Names

Darunavir

Paul A. Pham, Pharm.D., Janessa M. Smith, Pharm.D. BCPS, Alice Jenh Hsu, Pharm.D.
Darunavir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • HIV-infected patients who are treatment-experienced and have at least one DRV resistance mutation, in combination with other antiretrovirals (DRV/r 600/100 mg twice daily).
  • HIV-infected patients who are treatment-naive (DRV/r 800/100 mg once daily or DRV/c 800/150 mg once daily).
  • HIV-infected children (>3 years)

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: January 12, 2016